LP
LMR Partners’s Takeda Pharmaceutical TAK Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $535K | Sell |
34,600
-78,795
| -69% | -$1.22M | ﹤0.01% | 483 |
|
|
2025
Q1 | $1.69M | Sell |
113,395
-116,605
| -51% | -$1.73M | 0.02% | 352 |
|
|
2024
Q4 | $3.05M | Buy |
+230,000
| New | +$3.05M | 0.03% | 287 |
|
|
2024
Q2 | – | Sell |
-271,143
| Closed | -$3.77M | – | 960 |
|
|
2024
Q1 | $3.77M | Buy |
271,143
+178,128
| +192% | +$2.47M | 0.04% | 183 |
|
|
2023
Q4 | $1.33M | Sell |
93,015
-368,089
| -80% | -$5.25M | 0.02% | 266 |
|
|
2023
Q3 | $7.13M | Buy |
461,104
+362,114
| +366% | +$5.6M | 0.08% | 144 |
|
|
2023
Q2 | $1.56M | Buy |
+98,990
| New | +$1.56M | 0.02% | 284 |
|
|
2023
Q1 | – | Sell |
-151,409
| Closed | -$2.37M | – | 1152 |
|
|
2022
Q4 | $2.37M | Sell |
151,409
-437,205
| -74% | -$6.85M | 0.04% | 461 |
|
|
2022
Q3 | $7.66M | Buy |
+588,614
| New | +$7.66M | 0.14% | 172 |
|
|
2022
Q1 | – | Sell |
-507,814
| Closed | -$6.92M | – | 1342 |
|
|
2021
Q4 | $6.92M | Buy |
507,814
+191,800
| +61% | +$2.61M | 0.07% | 195 |
|
|
2021
Q3 | $5.25M | Sell |
316,014
-517,442
| -62% | -$8.6M | 0.06% | 242 |
|
|
2021
Q2 | $13.9M | Buy |
833,456
+657,812
| +375% | +$11M | 0.21% | 92 |
|
|
2021
Q1 | $3.2M | Buy |
+175,644
| New | +$3.2M | 0.08% | 227 |
|
|
2020
Q4 | – | Sell |
-2,446,614
| Closed | -$43.4M | – | 621 |
|
|
2020
Q3 | $43.4M | Sell |
2,446,614
-904,528
| -27% | -$16.1M | 0.89% | 13 |
|
|
2020
Q2 | $59.7M | Sell |
3,351,142
-92,843
| -3% | -$1.65M | 1.49% | 9 |
|
|
2020
Q1 | $53.4M | Buy |
3,443,985
+1,727,583
| +101% | +$26.8M | 2.49% | 8 |
|
|
2019
Q4 | $34.2K | Sell |
1,716,402
-820,482
| -32% | -$16.4K | 0.06% | 43 |
|
|
2019
Q3 | $43.3M | Sell |
2,536,884
-2,026,707
| -44% | -$34.6M | 2.14% | 11 |
|
|
2019
Q2 | $80.9M | Buy |
4,563,591
+3,171,256
| +228% | +$56.2M | 2.95% | 7 |
|
|
2019
Q1 | $28.4M | Buy |
+1,392,335
| New | +$28.4M | 1.45% | 16 |
|